Successful biotech day at Palais Brongniart in Paris

Organized by France Biotech and NYSE Euronext, the first Biotechnology day, sponsored by Hinvest partners, Bryan, Garnier & co, KBC securities and ING, has successfully gathered on January 31 some 21 European companies (Netherlands, Belgium, France) listed on NYSE Euronext, 70 biopharma investors and analysts, in the presence of 15 journalists.

After a morning dedicated to an assessment and the future of the biotechnological sector in Europe, more than 30 “one to one” and 40 “one to many” meetings were held between companies and investors.

Attendees:

• ABLYNX
• DEVGEN
• GALAPAGOS
• INNOGENETICS
• ONCOMETHYLOME
• THROMBOGENICS
• TIGENIX
• BIOALLIANCE PHARMA
• CELLECTIS
• FLAMEL TECHNOLOGIES
• GENFIT
• GENOWAY
• INNATE PHARMA
• METABOLIC EXPLORER
• NICOX
• TRANSGENE
• VIVALIS
• AMT
• CRUCELL
• PHARMING